Politics

The Readout Elaine Chen

STAT Plus: Exclusive: European VC Forbion hires Dyne CEO, expands in US

Health Rachel Cohrs Zhang

STAT Plus: Q&A: Lessons from the HHS secretary who ran Bush’s bird flu response

Biotech John Wilkerson

STAT Plus: FDA issues long-awaited draft guidance for enrolling more people of color in clinical trials

Health Sarah Owermohle

STAT Plus: The Supreme Court appears set to reject Idaho’s near-total abortion ban

Politics Rachel Cohrs Zhang

STAT Plus: House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound

Politics Sarah Owermohle

STAT Plus: Supreme Court rejects challenge to Biden’s use of bully pulpit to fight Covid misinformation

The Readout Elaine Chen

STAT Plus: Intellia says its CRISPR-based therapy can be redosed

First Opinion Anand Kumar

STAT Plus: CNN debate moderators could provide the cognitive tests that Biden and Trump have been avoiding

Politics Casey Ross and Bob Herman

Stop allowing MA plans to use AI to deny care without review, lawmakers urge CMS

D.C. Diagnosis Sarah Owermohle

STAT Plus: Senators push Medicare for a PET scan pay bump

The Readout Elaine Chen

STAT Plus: One firm, two conflicting takes on Alnylam’s HELIOS-B 

Politics Associated Press

STAT Plus: The Supreme Court will consider state bans on gender-affirming care for minors

The Readout Meghana Keshavan

STAT Plus: The findings from Alnylam’s highly anticipated readout  

Health tech Mohana Ravindranath

STAT Plus: Ateev Mehrotra, the researcher the telehealth lobby loves to hate, isn’t backing down

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests

The Readout Meghana Keshavan

STAT Plus: Can JAK inhibitors bolster checkpoint inhibitors? 

The Readout Elaine Chen

STAT Plus: Lilly takes more actions against unapproved versions of Mounjaro

D.C. Diagnosis Sarah Owermohle

STAT Plus: A new era for NIH

The Readout Adam Feuerstein

STAT Plus: A biotech’s binary bet ends badly

Politics Sarah Owermohle

STAT Plus: With sweeping NIH reform on the table, GOP previews new era of research scrutiny

A STAT Investigation Eric Boodman

This federal rule didn’t stop coercive sterilization — but it blocked contraceptive access. Can it be fixed?

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

Health Lev Facher

STAT Plus: Ambitious federal study failed to curb opioid deaths, NIH announces

Politics Rachel Cohrs Zhang

STAT Plus: Novo Nordisk CEO agrees to Bernie Sanders’ demand to testify on Ozempic, Wegovy prices

First Opinion Cathy McMorris Rodgers and Robert B. Aderholt

STAT Plus: NIH needs reform and restructuring, key Republican committee chairs say

The Readout Elaine Chen

STAT Plus: J.P. Morgan has officially jumped into early stage biotech investing

Biotech Sarah Owermohle, Allison DeAngelis, and Adam Feuerstein

STAT Plus: Biopharma execs cheer Supreme Court for upholding FDA authority in abortion pill case

Politics Sarah Owermohle

STAT Plus: Supreme Court unanimously rejects challenge to mailed abortion pills

The Readout Meghana Keshavan

With Avidity and Pfizer, gene therapy enters a phase